Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
Thursday, November 13, 2008 - 13:14
in Health & Medicine
The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology.